FDA Adverse Event Injury Summary report: N

EQUINOXE REVERSE SHOULDER SYSTEM

MDR report key: 24340850 · Received February 14, 2026

Report

Report Number
1038671-2026-00152
Event Type
Injury
Date Received
February 14, 2026
Date of Event
December 1, 2021
Report Date
February 14, 2026
Manufacturer
EXACTECH, INC.
Product Code
PHX
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

D10: HUMERAL STEM OR STEMLESS (CAT# 300-30-06). REVERSE HUMERAL TRAY (CAT# 320-10-00). REVERSE GLENOSPHERE (CA# 320-01-42). REVERSE GLENOSPHERE BASEPLATE (CAT# 320-15-01). H10: MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORT: 1038671-2026-00151. BASED ON REVIEW OF ALL AVAILABLE INFORMATION, THERE IS NO EVIDENCE TO SUGGEST THAT THE REPORTED EVENT IS RELATED TO ANY DESIGN OR MANUFACTURING ISSUES. THE CAUSE OF THE SHOULDER DISLOCATION AND INSTABILITY CANNOT BE CONCLUSIVELY DETERMINED; HOWEVER, IT IS MOST LIKELY RELATED TO THE PATIENT¿S UNDERLYING CONDITION AS ASSOCIATED WITH THE INTERACTION BETWEEN THE IMPLANTED DEVICE AND THE PATIENT DUE TO PATIENT ILLNESS, UNIQUE ANATOMY [OBESE], OR OTHER CONDITION THAT IMPACTS THE PERFORMANCE OF THE DEVICE. IF ANY FURTHER INFORMATION IS OBTAINED THAT WOULD CHANGE OR ALTER ANY INFORMATION PROVIDED, A SUPPLEMENTAL REPORT WILL BE FILED ACCORDINGLY.

Description of Event or Problem · 0

REPORT #2 OF 2 FOR THIS EVENT. AS REPORTED BY A CLINICAL STUDY, APPROXIMATELY TWO YEARS POST AN INITIAL RIGHT SIDE REVERSE TOTAL SHOULDER ARTHROPLASTY THE PATIENT EXPERIENCED INSTABILITY FOR ONE YEAR PRIOR TO A DISLOCATION. THE PATIENT REQUIRED PHYSICAL THERAPY. NO FURTHER PATIENT IMPACT WAS REPORTED. NO SURGICAL INTERVENTIONS WERE REPORTED. NO ADDITIONAL INFORMATION IS AVAILABLE. COULD NOT LOCATE INITIAL SURGERY IN EBI. 510K: K063569.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
401509 EQUINOXE REVERSE SHOULDER SYSTEM SHOULDER PROSTHESIS, REVERSE CONFIGURATION PHX EXACTECH, INC.

Patients

Seq Age Sex Outcome Treatment
1 72 YR Male Other SEE H11.